northern health gppo limited
northern health gppo limited Company Information
Company Number
09337374
Website
www.nhgppo.co.ukRegistered Address
victoria mill, lower vickers street, manchester, M40 7LH
Industry
General medical practice activities
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
gotodoc limited 8.1%
mohammad iqbal karim 5.4%
View Allnorthern health gppo limited Estimated Valuation
Pomanda estimates the enterprise value of NORTHERN HEALTH GPPO LIMITED at £3.6m based on a Turnover of £5.8m and 0.62x industry multiple (adjusted for size and gross margin).
northern health gppo limited Estimated Valuation
Pomanda estimates the enterprise value of NORTHERN HEALTH GPPO LIMITED at £0 based on an EBITDA of £-59.2k and a 5.18x industry multiple (adjusted for size and gross margin).
northern health gppo limited Estimated Valuation
Pomanda estimates the enterprise value of NORTHERN HEALTH GPPO LIMITED at £441.9k based on Net Assets of £1.6m and 0.28x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Northern Health Gppo Limited Overview
Northern Health Gppo Limited is a live company located in manchester, M40 7LH with a Companies House number of 09337374. It operates in the general medical practice activities sector, SIC Code 86210. Founded in December 2014, it's largest shareholder is gotodoc limited with a 8.1% stake. Northern Health Gppo Limited is a established, mid sized company, Pomanda has estimated its turnover at £5.8m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Northern Health Gppo Limited Health Check
Pomanda's financial health check has awarded Northern Health Gppo Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 2 areas for improvement. Company Health Check FAQs
6 Strong
3 Regular
2 Weak
Size
annual sales of £5.8m, make it larger than the average company (£2.1m)
- Northern Health Gppo Limited
£2.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 18%, show it is growing at a faster rate (7%)
- Northern Health Gppo Limited
7% - Industry AVG
Production
with a gross margin of 35.6%, this company has a comparable cost of product (35.6%)
- Northern Health Gppo Limited
35.6% - Industry AVG
Profitability
an operating margin of -1.1% make it less profitable than the average company (3.7%)
- Northern Health Gppo Limited
3.7% - Industry AVG
Employees
with 101 employees, this is above the industry average (24)
101 - Northern Health Gppo Limited
24 - Industry AVG
Pay Structure
on an average salary of £29.9k, the company has an equivalent pay structure (£29.9k)
- Northern Health Gppo Limited
£29.9k - Industry AVG
Efficiency
resulting in sales per employee of £57.7k, this is less efficient (£74.8k)
- Northern Health Gppo Limited
£74.8k - Industry AVG
Debtor Days
it gets paid by customers after 38 days, this is near the average (38 days)
- Northern Health Gppo Limited
38 days - Industry AVG
Creditor Days
its suppliers are paid after 39 days, this is slower than average (28 days)
- Northern Health Gppo Limited
28 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Northern Health Gppo Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 111 weeks, this is more cash available to meet short term requirements (41 weeks)
111 weeks - Northern Health Gppo Limited
41 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 26.8%, this is a lower level of debt than the average (62.3%)
26.8% - Northern Health Gppo Limited
62.3% - Industry AVG
NORTHERN HEALTH GPPO LIMITED financials
Northern Health Gppo Limited's latest turnover from March 2023 is estimated at £5.8 million and the company has net assets of £1.6 million. According to their latest financial statements, Northern Health Gppo Limited has 101 employees and maintains cash reserves of £1.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 3,552,266 | 3,893,836 | 3,079,060 | 1,695,040 | 1,443,786 | |||
| Other Income Or Grants | 0 | 0 | 0 | |||||
| Cost Of Sales | 2,314,354 | 2,000,405 | 613,647 | |||||
| Gross Profit | 1,237,912 | 1,893,431 | 2,465,413 | |||||
| Admin Expenses | 1,367,930 | 1,410,623 | 1,927,744 | |||||
| Operating Profit | -130,018 | 482,808 | 537,669 | 188,496 | 452,199 | |||
| Interest Payable | 1,238 | 0 | 5 | 0 | 0 | |||
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | |||
| Pre-Tax Profit | -131,256 | 482,808 | 537,664 | 188,496 | 452,199 | |||
| Tax | 24,556 | -91,480 | -102,056 | -38,074 | -89,353 | |||
| Profit After Tax | -106,700 | 391,328 | 435,608 | 150,422 | 362,846 | |||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | |||
| Retained Profit | -106,700 | 391,328 | 435,608 | 150,422 | 362,846 | |||
| Employee Costs | ||||||||
| Number Of Employees | 101 | 104 | 106 | 63 | 56 | 38 | 4 | |
| EBITDA* | -125,911 | 486,152 | 539,372 | 190,023 | 454,236 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 21,376 | 12,804 | 9,529 | 12,321 | 10,032 | 5,110 | 4,583 | 6,110 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 21,377 | 12,805 | 9,530 | 12,322 | 10,033 | 5,111 | 4,584 | 6,110 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 616,666 | 529,579 | 299,144 | 483,122 | 528,244 | 874,193 | 425,223 | 428,245 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 295,616 | 501,475 | 362,762 | 267,650 | 224,882 | 21,751 | 4,511 | 124 |
| Cash | 1,230,925 | 1,270,497 | 1,300,990 | 774,403 | 1,123,840 | 399,461 | 599,781 | 335,777 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,143,207 | 2,301,551 | 1,962,896 | 1,525,175 | 1,876,966 | 1,295,405 | 1,029,515 | 764,146 |
| total assets | 2,164,584 | 2,314,356 | 1,972,426 | 1,537,497 | 1,886,999 | 1,300,516 | 1,034,099 | 770,256 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 407,585 | 345,209 | 266,060 | 230,530 | 152,539 | 91,810 | 31,539 | 42,467 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 167,869 | 375,152 | 362,712 | 28,249 | 349,042 | 214,616 | 444,078 | 322,061 |
| total current liabilities | 575,454 | 720,361 | 628,772 | 258,779 | 501,581 | 306,426 | 475,617 | 364,528 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 5,344 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 5,344 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 580,798 | 720,361 | 628,772 | 258,779 | 501,581 | 306,426 | 475,617 | 364,528 |
| net assets | 1,583,786 | 1,593,995 | 1,343,654 | 1,278,718 | 1,385,418 | 994,090 | 558,482 | 405,728 |
| total shareholders funds | 1,583,786 | 1,593,995 | 1,343,654 | 1,278,718 | 1,385,418 | 994,090 | 558,482 | 405,728 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | -130,018 | 482,808 | 537,669 | 188,496 | 452,199 | |||
| Depreciation | 4,207 | 3,886 | 3,176 | 4,107 | 3,344 | 1,703 | 1,527 | 2,037 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 24,556 | -91,480 | -102,056 | -38,074 | -89,353 | |||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -118,772 | 369,148 | -88,866 | -2,354 | -142,818 | 466,210 | 1,365 | 428,369 |
| Creditors | 62,376 | 79,149 | 35,530 | 77,991 | 60,729 | 60,271 | -10,928 | 42,467 |
| Accruals and Deferred Income | -207,283 | 12,440 | 334,463 | -320,793 | 134,426 | -229,462 | 122,017 | 322,061 |
| Deferred Taxes & Provisions | 5,344 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -341,803 | 732,645 | -198,085 | 261,673 | 301,042 | |||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | -1,238 | 0 | -5 | 0 | 0 | |||
| cash flow from financing | -1,238 | 0 | -5 | 2,332 | 42,882 | |||
| cash and cash equivalents | ||||||||
| cash | -39,572 | -30,493 | 526,587 | -349,437 | 724,379 | -200,320 | 264,004 | 335,777 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -39,572 | -30,493 | 526,587 | -349,437 | 724,379 | -200,320 | 264,004 | 335,777 |
northern health gppo limited Credit Report and Business Information
Northern Health Gppo Limited Competitor Analysis
Perform a competitor analysis for northern health gppo limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in M40 area or any other competitors across 12 key performance metrics.
northern health gppo limited Ownership
NORTHERN HEALTH GPPO LIMITED group structure
Northern Health Gppo Limited has no subsidiary companies.
Ultimate parent company
NORTHERN HEALTH GPPO LIMITED
09337374
northern health gppo limited directors
Northern Health Gppo Limited currently has 3 directors. The longest serving directors include Ms Kathleen Toppin (Dec 2014) and Dr Amjad Ahmed (Dec 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Kathleen Toppin | England | 68 years | Dec 2014 | - | Director |
| Dr Amjad Ahmed | England | 42 years | Dec 2014 | - | Director |
| Dr Santosh Gholkar | England | 53 years | Mar 2017 | - | Director |
P&L
March 2023turnover
5.8m
+13%
operating profit
-63.4k
0%
gross margin
35.6%
-5.65%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
1.6m
-0.01%
total assets
2.2m
-0.06%
cash
1.2m
-0.03%
net assets
Total assets minus all liabilities
northern health gppo limited company details
company number
09337374
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
December 2014
age
10
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
March 2023
address
victoria mill, lower vickers street, manchester, M40 7LH
accountant
-
auditor
-
northern health gppo limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to northern health gppo limited.
northern health gppo limited Companies House Filings - See Documents
| date | description | view/download |
|---|
